"Natural" and "Organic" cigarette descriptors: association with expectancies, subjective effects, topography, and biomarkers of exposure among daily smokers

“天然”和“有机”香烟描述符:与日常吸烟者暴露的预期、主观效果、地形和生物标志物的关联

基本信息

  • 批准号:
    10487511
  • 负责人:
  • 金额:
    $ 45.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-15 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT Consumers believe that cigarettes with “organic,” “natural,” or similar descriptors are significantly more appealing, healthier, or less harmful than cigarettes without these descriptors. Nationwide, over 45% of US smokers believe that organic tobacco products are less harmful than conventional tobacco products. These misperceptions are even more pronounced among smokers of Natural American Spirit (NAS) cigarettes, who are 22 times more likely than other smokers to believe that their brand might be less harmful. There is some evidence that these misleading descriptors affect potential and current consumers’ smoking behavior, but results are based on self-report. The state of the research does not tell us how smokers interpret the subjective effects of using a “natural” or “organic” tobacco product, nor do we know if smokers’ interpretation of their subjective experience affects their actual smoking behavior and subsequent biological exposures. Guided by response expectancy theory, the purpose of this study is to examine the relationship between “natural” or “organic” descriptors and health risk expectancies, subjective effects, topography, and resulting biological exposures. Prior experimental research is limited to online brief exposure studies examining changes in health risk expectancies and intentions and has not included NAS smokers, who may have preexisting beliefs about “natural” or “organic” cigarettes that lead to more extreme favorable ratings of “natural” or “organic” cigarettes and more extreme negative ratings of conventional cigarettes than other smokers. The proposed research will examine how expectancies regarding “natural” or “organic” descriptors affect subjective effects (e.g., taste), topography (e.g., total puff volume), and acute exposures (e.g., salivary aldehyde concentrations), linking descriptors with smoking behavior and biomarkers of exposure among daily smokers of NAS and non-NAS cigarettes. To accomplish these aims, we will enroll 250 adult daily cigarette smokers of NAS or non-NAS brands (125 in each group) in a within-subjects human laboratory study manipulating four expectancy conditions (own brand comparator, “natural” advertising, “organic” advertising, “conventional” advertising). Given NAS smokers’ likely preexisting beliefs about natural/organic tobacco products, we will examine moderation by NAS preference in each hypothesis. Given women’s more favorable beliefs about organic products and preliminary data from our team, we will also examine moderation by gender in each hypothesis. This work addresses the FDA Center for Tobacco Products’ (CTP) goal to understand how changes in tobacco product characteristics (i.e., descriptors) are associated with knowledge, attitudes, and behaviors. Understanding how descriptors affect not only perceptions but also the subjective interpretation of using a cigarette is important as FDA CTP moves forward with regulating not just the packaging, but also the design of tobacco products. These descriptors may affect consumers’ interpretation of the subjective effects of smoking, leading to unexpected responses to regulatory actions meant to reduce the abuse liability or appeal of a product.
项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer Lynn Pearson其他文献

Jennifer Lynn Pearson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer Lynn Pearson', 18)}}的其他基金

"Natural" and "Organic" cigarette descriptors: association with expectancies, subjective effects, topography, and biomarkers of exposure among daily smokers
“天然”和“有机”香烟描述符:与日常吸烟者暴露的预期、主观效果、地形和生物标志物的关联
  • 批准号:
    10689781
  • 财政年份:
    2021
  • 资助金额:
    $ 45.79万
  • 项目类别:
"Natural" and "Organic" cigarette descriptors: association with expectancies, subjective effects, topography, and biomarkers of exposure among daily smokers
“天然”和“有机”香烟描述符:与日常吸烟者暴露的预期、主观效果、地形和生物标志物的关联
  • 批准号:
    10355168
  • 财政年份:
    2021
  • 资助金额:
    $ 45.79万
  • 项目类别:
EMA and Lab Assessment of Nicotine Dependence among Dual ENDS Users
EMA 和实验室对双 ENDS 用户尼古丁依赖性的评估
  • 批准号:
    8757366
  • 财政年份:
    2014
  • 资助金额:
    $ 45.79万
  • 项目类别:
A Mixed Methods EMA Assessment of Cognition and Behavior among New ENDS Users
新 ENDS 用户认知和行为的混合方法 EMA 评估
  • 批准号:
    8605695
  • 财政年份:
    2013
  • 资助金额:
    $ 45.79万
  • 项目类别:
A Mixed Methods EMA Assessment of Cognition and Behavior among New ENDS Users
新 ENDS 用户认知和行为的混合方法 EMA 评估
  • 批准号:
    8735114
  • 财政年份:
    2013
  • 资助金额:
    $ 45.79万
  • 项目类别:
The Effect of the Tobacco Control Act on Smoker's Intention to Quit Smoking
烟草控制法对吸烟者戒烟意愿的影响
  • 批准号:
    8001298
  • 财政年份:
    2010
  • 资助金额:
    $ 45.79万
  • 项目类别:
The Effect of the Tobacco Control Act on Smoker's Intention to Quit Smoking
烟草控制法对吸烟者戒烟意愿的影响
  • 批准号:
    8106132
  • 财政年份:
    2010
  • 资助金额:
    $ 45.79万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.79万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了